LINDSEY WALSH: Open Payments
NPI 1053682617 · PLANTATION, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 13 payments from 10 companies in 2025. Trend: 2023 $177 · 2024 $234 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 1 | $133 |
| PFIZER INC. | 1 | $123 |
| GENZYME CORPORATION | 2 | $69 |
| Almirall LLC | 2 | $53 |
| LNHC, Inc | 1 | $48 |
| Botanix SB Inc | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $37 |
| Incyte Corporation | 1 | $28 |
| Galderma Laboratories, L.P. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
Products named: DUPIXENT, LITFULO, Klisyri, ZELSUVMI, SOFDRA, OPZELURA, AKLIEF, RINVOQ.
Industry payments across FL — which companies pay providers there.
